|Title:||Effectiveness of half-a-tablet efavirenz plus 2 nucleos(t)ide reverse-transcriptase inhibitors as maintenance therapy with the guidance of therapeutic drug monitoring among virologically suppressed HIV-positive patients: A prospective study||Authors:||Huang, Sung-Hsi
|Keywords:||Combination antiretroviral therapy; Dose optimization; Non-nucleoside reverse-transcriptase inhibitor; Pharmacogenetics; Switch therapy||Issue Date:||29-May-2018||Source:||Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi||Abstract:||
Optimal efavirenz (EFV) dose that minimizes adverse effects while maintaining efficacy has yet to be elucidated. With a therapeutic drug monitoring (TDM)-guided strategy, we assessed the effectiveness of half-a-tablet EFV plus 2 nucleos(t)ide reverse-transcriptase inhibitors (NRTIs) in HIV-infected Taiwanese who had achieved viral suppression with full-dose (600 mg) EFV.
|Appears in Collections:||醫學系|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.